What other health conditions are weight-loss drugs being tested for? – CTV
March 11, 2024
Eli Lilly’s blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk’s rival medicines Ozempic and Wegovy, are being studied to see whether they can improve health in other ways.
The U.S. Food and Drug Administration on Friday approved Novo’s Wegovy for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.
Below are other conditions obesity treatments are being tested against:
A study by the University of Copenhagen’s Psychiatric Centre Rigshospitalet is investigating whether semaglutide, sold as Novo’s Wegovy and Ozempic, can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity.
